$2.68T
Total marketcap
$57.31B
Total volume
BTC 49.89%     ETH 17.08%
Dominance

Herborium HBRM Stock

0.0001 USD {{ price }} 0.000000% {{change_pct}}%
Market Cap
1.09M USD
LOW - HIGH [24H]
0.0001 - 0.0001 USD
VOLUME [24H]
251.49K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Herborium Price Chart

Herborium HBRM Financial and Trading Overview

Herborium stock price 0.0001 USD
Previous Close 0.0001 USD
Open 0.0001 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.0001 - 0.0001 USD
52 Week Range 5.0E-5 - 0.0005 USD
Volume 3M USD
Avg. Volume 32.29M USD
Market Cap 220.29K USD
Beta (5Y Monthly) 89.50845
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

HBRM Valuation Measures

Enterprise Value 419.26K USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.8502277
Price/Book (mrq) N/A
Enterprise Value/Revenue 1.618
Enterprise Value/EBITDA -1.676

Trading Information

Herborium Stock Price History

Beta (5Y Monthly) 89.50845
52-Week Change -50.00000000000000000000000000000000%
S&P500 52-Week Change 20.43%
52 Week High 0.0005 USD
52 Week Low 5.0E-5 USD
50-Day Moving Average 0.000105 USD
200-Day Moving Average 0.0001675 USD

HBRM Share Statistics

Avg. Volume (3 month) 32.29M USD
Avg. Daily Volume (10-Days) 6.48M USD
Shares Outstanding 2.2B
Float N/A
Short Ratio 0
% Held by Insiders 0%
% Held by Institutions 0%
Shares Short 0
Short % of Float N/A
Short % of Shares Outstanding 0%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:1000

Financial Highlights

Fiscal Year

Fiscal Year Ends November 30, 2011
Most Recent Quarter (mrq) August 31, 2012
Next Fiscal Year End November 30, 2012

Profitability

Profit Margin 26.32%
Operating Margin (ttm) -98.031%
Gross Margin 64.99%
EBITDA Margin -96.56%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 259.1K USD
Revenue Per Share (ttm) 0.44 USD
Quarterly Revenue Growth (yoy) 22.50%
Gross Profit (ttm) 125.4K USD
EBITDA -250200 USD
Net Income Avi to Common (ttm) 68.2K USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 120.1K USD
Total Cash Per Share (mrq) 0.2 USD
Total Debt (mrq) 539.3K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) N/A
Book Value Per Share (mrq) -2.03

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Herborium

Country United States
State NJ
City Fort Lee
Address One Bridge Plaza North
ZIP 07024
Phone 201-849-4431
Website https://www.herborium.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 2

Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy. In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to decrease the symptoms associated with hangovers and eliminating jet-lag; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands. Further, the company provides Liver Activator Series for the treatment of liver damage; ProstAid, a natural product focuses on Benign Prostate Hyperplasia; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. Herborium Group, Inc. sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey.

Q&A For Herborium Stock

What is a current HBRM stock price?

Herborium HBRM stock price today per share is 0.0001 USD.

How to purchase Herborium stock?

You can buy HBRM shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Herborium?

The stock symbol or ticker of Herborium is HBRM.

Which industry does the Herborium company belong to?

The Herborium industry is Drug Manufacturers-Specialty & Generic.

How many shares does Herborium have in circulation?

The max supply of Herborium shares is 10.92B.

What is Herborium Price to Earnings Ratio (PE Ratio)?

Herborium PE Ratio is now.

What was Herborium earnings per share over the trailing 12 months (TTM)?

Herborium EPS is 0 USD over the trailing 12 months.

Which sector does the Herborium company belong to?

The Herborium sector is Healthcare.